This brand name is authorized in Ecuador
The drug SIROGAL contains a combination of these active pharmaceutical ingredients (APIs):
1
Demorphan
UNII 351KFH969D - DEXTROMETHORPHAN HYDROCHLORIDE
|
Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. |
2
Guaiacol
UNII 6JKA7MAH9C - GUAIACOL
|
|
3
Ammonium chloride
UNII 01Q9PC255D - AMMONIUM CHLORIDE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R05FA02 | Opium derivatives and expectorants | R Respiratory system → R05 Cough and cold preparations → R05F Cough suppressants and expectorants, combinations → R05FA Opium derivatives and expectorants |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 04310-MAN-07-06 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.